These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15123254)

  • 41. A highly active single-mutation variant of P450BM3 (CYP102A1).
    Whitehouse CJ; Bell SG; Yang W; Yorke JA; Blanford CF; Strong AJ; Morse EJ; Bartlam M; Rao Z; Wong LL
    Chembiochem; 2009 Jul; 10(10):1654-6. PubMed ID: 19492389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hybrid enzymes.
    Béguin P
    Curr Opin Biotechnol; 1999 Aug; 10(4):336-40. PubMed ID: 10449312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterologous expression, purification, and characterization of cytochrome P450sca-2 and mutants with improved solubility in Escherichia coli.
    Li P; Guan H; Li J; Lin Z
    Protein Expr Purif; 2009 Jun; 65(2):196-203. PubMed ID: 19100328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein and electrode engineering for the covalent immobilization of P450 BMP on gold.
    Ferrero VE; Andolfi L; Di Nardo G; Sadeghi SJ; Fantuzzi A; Cannistraro S; Gilardi G
    Anal Chem; 2008 Nov; 80(22):8438-46. PubMed ID: 18947200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural divergence and adaptive evolution in mammalian cytochromes P450 2C.
    da Fonseca RR; Antunes A; Melo A; Ramos MJ
    Gene; 2007 Jan; 387(1-2):58-66. PubMed ID: 17045425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparative use of isolated CYP102 monooxygenases -- a critical appraisal.
    Eiben S; Kaysser L; Maurer S; Kühnel K; Urlacher VB; Schmid RD
    J Biotechnol; 2006 Aug; 124(4):662-9. PubMed ID: 16716428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of the polyene macrolide P450 epoxidase from Streptomyces natalensis that converts de-epoxypimaricin into pimaricin.
    Mendes MV; Antón N; Martín JF; Aparicio JF
    Biochem J; 2005 Feb; 386(Pt 1):57-62. PubMed ID: 15228385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
    Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH
    Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple mutagenesis of P450 isoflavonoid synthase reveals a key active-site residue.
    Sawada Y; Ayabe S
    Biochem Biophys Res Commun; 2005 May; 330(3):907-13. PubMed ID: 15809082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring the potential of xenobiotic-metabolising enzymes as biocatalysts: evolving designer catalysts from polyfunctional cytochrome P450 enzymes.
    Gillam EM
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):147-52. PubMed ID: 15743395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are transversion mutations better? A Mutagenesis Assistant Program analysis on P450 BM-3 heme domain.
    Wong TS; Roccatano D; Schwaneberg U
    Biotechnol J; 2007 Jan; 2(1):133-42. PubMed ID: 17183510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Engineering cytochrome P450 enzymes for improved activity towards biomimetic 1,4-NADH cofactors.
    Ryan JD; Fish RH; Clark DS
    Chembiochem; 2008 Nov; 9(16):2579-82. PubMed ID: 18816544
    [No Abstract]   [Full Text] [Related]  

  • 53. Site-directed protein recombination as a shortest-path problem.
    Endelman JB; Silberg JJ; Wang ZG; Arnold FH
    Protein Eng Des Sel; 2004 Jul; 17(7):589-94. PubMed ID: 15331774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Knotted fusion proteins reveal unexpected possibilities in protein folding.
    Mallam AL; Onuoha SC; Grossmann JG; Jackson SE
    Mol Cell; 2008 Jun; 30(5):642-8. PubMed ID: 18538662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional expression of N-terminally tagged membrane bound cytochrome P450.
    Hamann T; Laursen T; Møller BL
    Protein Expr Purif; 2009 Nov; 68(1):18-21. PubMed ID: 19523520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biotransformation of beta-ionone by engineered cytochrome P450 BM-3.
    Urlacher VB; Makhsumkhanov A; Schmid RD
    Appl Microbiol Biotechnol; 2006 Mar; 70(1):53-9. PubMed ID: 16001257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytochromes P450 and drug discovery.
    Lamb DC; Waterman MR; Kelly SL; Guengerich FP
    Curr Opin Biotechnol; 2007 Dec; 18(6):504-12. PubMed ID: 18006294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of redox potential and alteration in reactivity via the peroxide shunt pathway by mutation of cytochrome P450 around the proximal heme ligand.
    Matsumura H; Wakatabi M; Omi S; Ohtaki A; Nakamura N; Yohda M; Ohno H
    Biochemistry; 2008 Apr; 47(16):4834-42. PubMed ID: 18363338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characterization of cytochrome P450 catalyzing hydroxylation of benzoates from the white-rot fungus Phanerochaete chrysosporium.
    Matsuzaki F; Wariishi H
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1184-90. PubMed ID: 16039998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.